https://www.selleckchem.com/pr....oducts/deutenzalutam
The VHI and VAS scores as subjective parameters also improved. In the abductor SD group, one patient responded to treatment. Adverse events included breathy hoarseness (77.3%) and aspiration when drinking (40.9%) but were mild and resolved in 4weeks. Botulinum toxin injection was safe and efficacious for the treatment of SD. Based on these results, BT injection therapy was approved as an SD treatment in Japan. Botulinum toxin injection was safe and efficacious for the treatment of SD. Based on these results, BT injection therap